Copyright Reports & Markets. All rights reserved.

Global Parkinson's Disease Therapeutics Sales Market Report 2019 by Manufacturer, Region, Type and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Parkinson's Disease Therapeutics Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Medications Therapeutics
      • 2.1.2 Medical Devices Therapeutics
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Medications Therapeutics
      • 2.2.2 Medical Devices Therapeutics

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Under 40 Years Old
      • 3.1.2 40-65 Years Old
      • 3.1.3 Above 65 Years Old

    4 Manufacturers Profiles/Analysis

    • 4.1 GSK
      • 4.1.1 GSK Profiles
      • 4.1.2 GSK Product Information
      • 4.1.3 GSK Parkinson's Disease Therapeutics Business Performance
      • 4.1.4 GSK Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.2 Novartis
      • 4.2.1 Novartis Profiles
      • 4.2.2 Novartis Product Information
      • 4.2.3 Novartis Parkinson's Disease Therapeutics Business Performance
      • 4.2.4 Novartis Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.3 Boehringer Ingelheim
      • 4.3.1 Boehringer Ingelheim Profiles
      • 4.3.2 Boehringer Ingelheim Product Information
      • 4.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Business Performance
      • 4.3.4 Boehringer Ingelheim Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.4 Teva Pharmaceutical
      • 4.4.1 Teva Pharmaceutical Profiles
      • 4.4.2 Teva Pharmaceutical Product Information
      • 4.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Business Performance
      • 4.4.4 Teva Pharmaceutical Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.5 Abbvie
      • 4.5.1 Abbvie Profiles
      • 4.5.2 Abbvie Product Information
      • 4.5.3 Abbvie Parkinson's Disease Therapeutics Business Performance
      • 4.5.4 Abbvie Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.6 Merck
      • 4.6.1 Merck Profiles
      • 4.6.2 Merck Product Information
      • 4.6.3 Merck Parkinson's Disease Therapeutics Business Performance
      • 4.6.4 Merck Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.7 Akorn
      • 4.7.1 Akorn Profiles
      • 4.7.2 Akorn Product Information
      • 4.7.3 Akorn Parkinson's Disease Therapeutics Business Performance
      • 4.7.4 Akorn Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.8 Kyowa Hakko Kirin Pharma
      • 4.8.1 Kyowa Hakko Kirin Pharma Profiles
      • 4.8.2 Kyowa Hakko Kirin Pharma Product Information
      • 4.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Business Performance
      • 4.8.4 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.9 Astellas Pharma
      • 4.9.1 Astellas Pharma Profiles
      • 4.9.2 Astellas Pharma Product Information
      • 4.9.3 Astellas Pharma Parkinson's Disease Therapeutics Business Performance
      • 4.9.4 Astellas Pharma Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.10 Desitin Arzneimittel
      • 4.10.1 Desitin Arzneimittel Profiles
      • 4.10.2 Desitin Arzneimittel Product Information
      • 4.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Business Performance
      • 4.10.4 Desitin Arzneimittel Parkinson's Disease Therapeutics Business Development and Market Status
    • 4.11 Endo Pharmaceuticals
    • 4.12 F.Hoffmann-La Roche
    • 4.13 H.Lundbeck
    • 4.14 Valeant
    • 4.15 Apokyn
    • 4.16 Orion
    • 4.17 Stada Arzneimittel
    • 4.18 US WorldMeds
    • 4.19 Valeant Pharmaceuticals

    5 Market Performance for Manufacturers

    • 5.1 Global Parkinson's Disease Therapeutics Sales (K Units) and Market Share by Manufacturers 2014-2019
    • 5.2 Global Parkinson's Disease Therapeutics Revenue (M USD) and Market Share by Manufacturers 2014-2019
    • 5.3 Global Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
    • 5.4 Global Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.1.2 China Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.1.3 China Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.1.4 China Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.2.2 USA Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.2.3 USA Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.2.4 USA Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.3.2 Europe Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.3.3 Europe Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.3.4 Europe Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.4.2 Japan Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.4.3 Japan Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.4.4 Japan Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.5.2 Korea Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.5.3 Korea Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.5.4 Korea Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.6.2 India Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.6.3 India Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.6.4 India Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.7.2 Southeast Asia Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.7.3 Southeast Asia Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.7.4 Southeast Asia Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Parkinson's Disease Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.8.2 South America Parkinson's Disease Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.8.3 South America Parkinson's Disease Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.8.4 South America Parkinson's Disease Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.8.5 Market Concentration

    7 Global Parkinson's Disease Therapeutics Market Performance (Sales Point)

    • 7.1 Global Parkinson's Disease Therapeutics Sales (K Units) and Market Share by Regions 2014-2019
    • 7.2 Global Parkinson's Disease Therapeutics Revenue (M USD) and Market Share by Regions 2014-2019
    • 7.3 Global Parkinson's Disease Therapeutics Price (USD/Unit) by Regions 2014-2019
    • 7.4 Global Parkinson's Disease Therapeutics Gross Margin by Regions 2014-2019

    8 Development Trend for Regions (Sales Point)

    • 8.1 Global Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.2 China Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.3 USA Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate2014-2019
    • 8.4 Europe Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.5 Japan Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.6 Korea Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.7 India Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Parkinson's Disease Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Under 40 Years Old Industry
    • 11.2 40-65 Years Old Industry
    • 11.3 Above 65 Years Old Industry

    12 Market Forecast 2020-2025

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
      • 12.1.1 Global Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
      • 12.1.2 Global Parkinson's Disease Therapeutics Sales (K Units) and Growth Rate 2020-2025
      • 12.1.3 China Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.4 USA Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.5 Europe Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.6 Japan Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.7 Korea Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.8 India Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.9 Southeast Asia Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.10 South America Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2020-2025
      • 12.2.1 Overall Market Performance
      • 12.2.2 Medications Therapeutics
      • 12.2.3 Medical Devices Therapeutics
    • 12.3 Sales (K Units) Forecast by Application 2020-2025
      • 12.3.1 Overall Market Performance
      • 12.3.2 Under 40 Years Old
      • 12.3.3 40-65 Years Old
      • 12.3.4 Above 65 Years Old
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Parkinson's Disease Therapeutics Price (USD/Unit) Trend 2020-2025
      • 12.4.2 Global Parkinson's Disease Therapeutics Gross Profit Trend 2020-2025

    13 Conclusion

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Parkinson's Disease Therapeutics for these regions, from 2012 to 2023 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Parkinson's Disease Therapeutics market competition by top manufacturers/players, with Parkinson's Disease Therapeutics sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Merck
    Akorn
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Valeant Pharmaceuticals
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Medications Therapeutics
    Medical Devices Therapeutics
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Parkinson's Disease Therapeutics for each application, including
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now